Showing results (81-90 of 134) with videos related to
Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue TherapyMark Anderson, Jeffery Gersch, Ka-Cheung Luk, et al.BMC Public Health|June 30, 2017
Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Paul M Trembling, Sophia Apostolidou, Aleksandra Gentry-Maharaj, et al.BMC Gastroenterology|July 13, 2019
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseAnkur Srivastava, Simcha Jong, Anna Gola, et al.Sensors (Basel, Switzerland)|January 8, 2023
An Overview of Fog Data Analytics for IoT ApplicationsJitendra Bhatia, Kiran Italiya, Kuldeepsinh Jadeja, et al.BMC Gastroenterology|March 11, 2022
The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?Sara Cococcia, Priti Dutta, Melika Moghim, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 14, 2004
Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis CPaolo Fabris, Dave Brown, Giulia Tositti, et al.Journal of Virology|May 14, 2004
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyGeorge J M Webster, Stephanie Reignat, David Brown, et al.Journal of Hepatology|February 11, 2014
Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation modelHamish Innes, David Goldberg, Geoffrey Dusheiko, et al.Journal of Hepatology|April 10, 2019
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver diseaseAnkur Srivastava, Ruth Gailer, Sudeep Tanwar, et al.Plos Pathogens|March 22, 2013
The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cellsAnna Schurich, Laura J Pallett, Marcin Lubowiecki, et al.Pageof 14